Month: March 2025

XAI Madison Equity Premium Income Fund Declares its Quarterly Distribution of $0.18 per Share – Fund to Change Distribution Frequency

Written by Customer Service on March 3, 2025. Posted in Dividend Reports And Estimates.

CHICAGO, March 03, 2025 (GLOBE NEWSWIRE) — XAI Madison Equity Premium Income Fund (the “Fund” or “MCN”) has declared its regular quarterly distribution of $0.18 per share on the Fund’s common shares, payable on April 1, 2025, to shareholders of record as of March 17, 2025, as noted below. The amount of the distribution represents no change from the previous quarter’s distribution amount of $0.18 per common share. In addition, the Fund announced that it will change its distribution frequency from quarterly to monthly. The first monthly declaration will be made on April 1, 2025, and the first monthly distribution will be made on May 1, 2025. Kimberly Flynn, President of XA Investments, said, “MCN has a long history of making consistent periodic payments to shareholders. We believe the change to monthly distributions will enable investors...

The Ensign Group Continues Growth in Arizona

Written by Customer Service on March 3, 2025. Posted in Mergers And Acquisitions.

SAN JUAN CAPISTRANO, Calif., March 03, 2025 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the real estate and operations of Citrus Heights Respiratory and Rehabilitation, a 204-bed skilled nursing facility; and Springdale Village Post Acute, a 122-bed skilled nursing facility, both located in Mesa, Arizona. The real estate was acquired by a subsidiary of Standard Bearer Healthcare REIT, Inc., Ensign’s captive real estate company, and the acquisition is effective as of March 1, 2025. “Arizona continues to be one of our most mature and strongest platforms...

Jamf announces intent to acquire Identity Automation to bring identity and device management together in one powerful, secure platform

Written by Customer Service on March 3, 2025. Posted in Mergers And Acquisitions.

Identity Automation adds dynamic and automated role-based access capability to Jamf’s endpoint management and security platform MINNEAPOLIS, March 03, 2025 (GLOBE NEWSWIRE) — Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, today announced it signed a definitive agreement to acquire Identity Automation. Identity Automation is a dynamic identity and access management (IAM) platform for industries that are defined by frequent role adjustments, such as education and healthcare. Identity Automation’s comprehensive and advanced IAM platform automates identity and access management workflows to significantly reduce IT burden and enhance the user experience. With Identity Automation, Jamf will combine identity with device access in one unique solution, helping ensure secure devices and application access. A dynamic...

CTO Realty Growth Announces Acquisition of Lifestyle Center in Atlanta, Georgia for $79.8 Million

Written by Customer Service on March 3, 2025. Posted in Mergers And Acquisitions.

WINTER PARK, Fla., March 03, 2025 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”), a leading owner and operator of high-quality, open-air shopping centers located in the higher growth Southeast and Southwest markets of the United States, today announced the acquisition of Ashley Park (the “Property”), a 559,000-square-foot, 60-acre, lifestyle center in the Newnan submarket of Atlanta, Georgia for a purchase price of $79.8 million. The purchase price represents a going-in cap rate near the high end of the Company’s current guidance range for initial cash yields. The acquisition increases the total portfolio by 12%, to 5.2 million square feet. “This acquisition enhances our portfolio by adding another lifestyle shopping center in Atlanta, our largest market, while leveraging our local personnel...

ThredUp Announces Fourth Quarter and Full Year 2024 Results

Written by Customer Service on March 3, 2025. Posted in Earnings Releases And Operating Results.

All results reported are continuing operations, unless otherwise notedQuarterly revenue of $67.3 million, representing an increase of 9% year-over-year. Record fourth quarter gross margin of 80.4%. Record full year revenue of $260.0 million, representing 1% growth year-over-year. Record full year gross margin of 79.7%. Active Buyers of 1,274 thousand and Orders of 1,226 thousand in Q4 2024, representing year-over-year decrease of 6% and increase of 2%, respectively.OAKLAND, Calif., March 03, 2025 (GLOBE NEWSWIRE) — ThredUp Inc. (Nasdaq: TDUP, LTSE: TDUP), one of the largest online resale platforms for apparel, shoes, and accessories, today announced its financial results for the fourth quarter and full year ended December 31, 2024. “We are proud to have closed out 2024 with a definitive return to growth, while also delivering...

GigaCloud Technology Inc Announces Fourth Quarter and Year Ended December 31, 2024 Financial Results

Written by Customer Service on March 3, 2025. Posted in Earnings Releases And Operating Results.

Record Total Revenues in 2024 Reach More Than $1 Billion EL MONTE, Calif., March 03, 2025 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced financial results for the fourth quarter and fiscal year ended December 31, 2024, including a milestone achievement of surpassing $1 billion in total annual revenues for the first time in 2024, and continued robust growth in GigaCloud Marketplace GMV. Fourth Quarter 2024 Financial HighlightsTotal revenues of $295.8 million, increased 20.9% year-over-year. Gross profit of $65.0 million, decreased 6.9% year-over-year. Gross margin was 22.0%, compared to 28.5% in the fourth quarter of 2023. Net income of $31.0 million, decreased 12.9% year-over-year....

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Written by Customer Service on March 3, 2025. Posted in Earnings Releases And Operating Results.

Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia Patient base increased 56% in 2024 over 2023 to approximately 6,000 global patients GERMANTOWN, Md., March 03, 2025 (GLOBE NEWSWIRE) — Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the fourth quarter ended December 31, 2024. Recent Highlights & Accomplishments:Eversense® 365 approved and launched in the U.S. during 2024 as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes Patient base increased 56% in 2024 over 2023 to approximately...

Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results

Written by Customer Service on March 3, 2025. Posted in Earnings Releases And Operating Results.

SAN RAFAEL, Calif., March 03, 2025 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months ended December 31, 2024. Recent Highlights and AccomplishmentsRecord Q4-2024 revenue of $5.1 million Q4-2024 gross margin increased 400 basis points year-over-year to 53% Subsequent to year-end, Company named National Seating & Mobility as its exclusive Ekso Indego® Personal device distributor within the U.S. complex rehabilitation technology (CRT) industry“We are pleased to close out 2024 with record fourth quarter revenue, improved gross margin and growing interest in our unrivalled portfolio of Enterprise Health and Personal Health devices,” said...

ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Written by Customer Service on March 3, 2025. Posted in Earnings Releases And Operating Results.

FY 2024 Total Revenue of $426.5 Million, a 65% YoY Increase FY 2024 GAAP Net Income of $197.7 Million, Including an $84.3 Million Valuation Allowance Tax Benefit FY 2024 Adjusted EBITDA(1) of $164.6 Million, a 309% YoY Increase FY 2024 Adjusted Net Income(2) of $119.2 Million, Compared to $0.7 Million in FY 2023, a 16,810% YoY Increase YE 2024 Total Cash Grew to More than $103 Million, Including $60 Million of Debt Organically Discharged During 2H 2024 High-Titer Plasma Supply Contracts Expected to Provide Foundation for Durable ASCENIV Revenue Growth Through Late 2030s FDA Approval of Yield Enhancement Production Process Anticipated by Mid-2025 FY 2025 and 2026 Total Revenue Guidance Increased to More than $490 Million and $605 Million, Respectively FY 2025 and 2026 Adjusted Net Income Guidance Increased to More Than $175 Million...

Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Written by Customer Service on March 3, 2025. Posted in Earnings Releases And Operating Results.

Strong patient and physician demand for pivotal REMAIN-1 study highlights urgent need for post-GLP-1 withdrawal weight maintenance solutions; midpoint data analysis anticipated in Q2 2025 and full study enrollment expected in summer 2025 Company plans to submit first Clinical Trial Application (CTA) module for RJVA-001 in type 2 diabetes to regulators in H1 2025, and if CTA is authorized, expects to report preliminary data in 2026 Conference call today at 4:30 p.m. ET BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (“the Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D), is redefining the future of metabolic health by tackling one of obesity care’s most urgent challenges – sustaining weight loss after...

Month: March 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals